m-maleimidobenzoyl-N-hydroxysulfosuccinimide ester,
m-maleimidobenzoyl-N-hydroxysulphosuccinimide ester,
MBS crosslinker,
sulfo-MBS,
sulpho-MBS,
Sulfo-mbs,
1-{[3-(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)benzoyl]oxy}-2,5-dioxo-3-pyrrolidinesulfonic acid,
92921-25-0,
Sulpho-mbs,
C15H10N2O9S,
Sulpho MBS,
m-Maleimidobenzoyl-N-hydroxysulfosuccinimide ester,
103848-62-0,
AC1L3Z7D,
AC1Q6NV4,
m-Maleimidobenzoyl-N-hydroxysulphosuccinimide ester,
SCHEMBL4289308,
CTK8D6687,
DIYPCWKHSODVAP-UHFFFAOYSA-N,
ZX-AFC000042,
5356AH,
1-((3-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)benzoyl)oxy)-2,5-dioxo-3-pyrrolidinesulfonic acid,
3-Maleimidobenzoyl-N-hydroxysulphosuccinimide ester,
3-Maleimidobenzoyl-N-hydroxysulphosuccinimide ester sodium salt,
1-[3-(2,5-dioxopyrrol-1-yl)benzoyl]oxy-2,5-dioxopyrrolidine-3-sulfonic acid,
3-Pyrrolidinesulfonic acid, 1-((3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)benzoyl)oxy)-2,5-dioxo-,
Brbdla,
Benzyldimethyllaurylammonium,
Benzyldimethyllaurylammonium bromide,
AR-1B9609,
C15-H10-N2-O9-S,
CID124851,
98790-49-9,
Sulfo-MBS (m-Maleimidobenzoyl-N-hydroxysulfosuccinimide ester), 95% - 10MG 10mg,